Section Head Ian Cree (Acting) Group Head Kate Z. Guyton (Acting) Section Secretary Lucy Shedden Scientists Lamia Benbrahim-Tallaa (toxicology/carcinogenesis) Véronique Bouvard (infection and carcinogenesis) Fatiha El Ghissassi (biochemistry/genetic toxicology) Jennifer Girschik (epidemiology) Yann Grosse (carcinogenesis/bioassays) Amy Hall (postdoctoral fellow, exposure…
Instructions for Authors for the Preparation of Drafts for IARC Monographs These Instructions for Authors were prepared by staff of the IARC Monographs programme and are provided to members of the Working Group to guide them in preparing the first…
The Preamble to the IARC Monographs describes the objective and scope of the programme, the scientific principles and procedures used in developing a Monograph, the types of evidence considered, and the scientific criteria that guide the evaluations. The Preamble should be consulted when…
Advisory Group to Recommend an Update to the Preamble Participants (12–14 November 2018) Scientific Webinar, 17 September 2018: agenda; slides; video Public Comments Q&A on the updating of the Preamble to the IARC Monographs (updated on 6 July 2018) Summary Statement…
The terms of use of the IARC Monographs are described here Select link to view full volume and (since Volume 88) summary in The Lancet Oncology For older volumes, the date given is the year of printing. For Volume 115…
Group 1 Carcinogenic to humans 129 agents Group 2A Probably carcinogenic to humans 96 agents Group 2B Possibly carcinogenic to humans 321 agents Group 3 Not classifiable as to its carcinogenicity to humans 499 agents For definitions of these groups,…